| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document

Title:Nujnost pravne ureditve redkih bolezni : diplomsko delo
Authors:Breg, Aleksandra (Author)
Kraljić, Suzana (Mentor) More about this mentor... New window
Files:.pdf UN_Breg_Aleksandra_2019.pdf (1019,72 KB)
 
Language:Slovenian
Work type:Bachelor thesis/paper (mb11)
Typology:2.11 - Undergraduate Thesis
Organization:PF - Faculty of Law
Abstract:V diplomskem delu je obravnavana problematika redkih bolezni, bolezni, za katerimi zboli majhen del prebivalstva. Čeprav se Evropska unija in države članice trudijo izboljšati položaj pacientov z redkimi boleznimi, so ti še vedno v zapostavljenem položaju. Glavni razlog je v pomanjkljivi pravni ureditvi področja redkih bolezni, pa tudi v omejenih pristojnostih Evropske unije na področju javnega zdravja. Pozitivno ukrepanje držav članic in Evropske unije je na tem področju potrebno, da se pacientom z redkimi boleznimi zagotovi pravica do zdravja in enaka obravnava v primerjavi s pacienti s pogostejšimi boleznimi. Pacienti z redkimi boleznimi se soočajo s številnimi težavami pri diagnosticiranju, zdravljenju in oskrbi, kar se odraža na njihovi kakovosti življenja in življenja njihovih bližnjih. Pacienti z redkimi boleznimi so tako podvrženi več vidikom diskriminacije, predvsem pri zdravstvenem varstvu, socialnem življenju ter izobraževalnih in poklicnih možnostih. Zaradi majhnega števila ljudi, ki zbolijo za posamezno redko boleznijo, in pomanjkanja strokovnega znanja o redkih boleznih, je sodelovanje med državami članicami Evropske unije nujno. Tako so za paciente z redkimi boleznimi pomembne evropske referenčne mreže in čezmejno zdravstveno varstvo. Za diagnosticiranje, zdravljenje in preprečevanje redkih bolezni se uporabljajo zdravila sirote, ki so običajno veliko dražja kot preostala zdravila. Pogosto se zato pojavijo težave pri povračilu stroškov zdravljenja pacientov z redkimi boleznimi. Ustrezno in primerno zdravstveno varstvo v državi zdravstvenega zavarovanja pacienta ni vedno na voljo, zato se pacientom z redkimi boleznimi omogoča uporaba zdravstvenih storitev v drugi državi članici.
Keywords:pacienti z redkimi boleznimi, zdravila sirote, pravica do zdravja, diskriminacija, čezmejno zdravstveno varstvo, načelo enakosti.
Year of publishing:2019
Place of performance:Maribor
Publisher:[A. Breg]
Number of pages:39 f.
Source:Maribor
UDC:342.7:004.738.5(043.2)
COBISS_ID:5730091 Link is opened in a new window
NUK URN:URN:SI:UM:DK:ZKTFFDEI
License:CC BY-NC-ND 4.0
This work is available under this license: Creative Commons Attribution Non-Commercial No Derivatives 4.0 International
Views:372
Downloads:62
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Categories:PF
:
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:English
Title:Legal regulation necessity of rare diseases
Abstract:The thesis discusses the issue of rare diseases, diseases affecting only a small portion of the population. Although the European Union and its Member States are trying to improve the position of patients with rare diseases, they are still in a disadvantaged position. The main reason for this is insufficient legal regulation of the field of rare diseases in addition to limited jurisdiction of the European Union in the field of public health. Positive measures of Member States and the European Union in this field are needed in order to assure patients with rare diseases their right to health and equal treatment to that provided to patients with more common diseases. Patients with rare diseases are facing numerous problems in terms of diagnostics, treatment and care, which is reflecting on the quality of life of these patients and their close ones. Patients with rare diseases are thus subjected to more types of discrimination, particularly in terms of healthcare, social life and education and career possibilities. Cooperation between Member States of the European Union is crucial due to a low number of people, suffering from a rare disease, and a lack of professional knowledge on rare diseases. European reference networks and cross-border healthcare are important for patients with rare diseases. Orphan medicinal products are used for the diagnosing, treatment and prevention of rare diseases. These are usually much more costly than other medicines, which is why the compensation of costs for treatment of patients with rare diseases is often connected with problems. Adequate and appropriate healthcare is not always available in the State of the patient's health insurance, which is why patients with rare diseases are allowed to use health services in other Member States.
Keywords:patients with rare diseases, orphan medicinal products, right to health, discrimination, cross-border healthcare, principle of equal treatment.


Comments

Leave comment

You have to log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica